Lytus Technologies Acquires Blod.in – India’s First AI Powered Blood Logistics Company for Hospitals
Commits INR 1000 crore to Power AI-Driven Scaling, Innovation,
Cipla, Glenmark shares hit 52-week high over launch of COVID-19 drugs
Cipla's shares on Monday surged 9.2% to hit a new 52-week high of ₹696 on BSE. This comes after it was allowed to manufacture
India records nearly 11,000 coronavirus recoveries in last 24 hours
As many as 10,994 coronavirus recoveries were recorded in India in the last 24 hours, taking the total number of patients who have been
Give details of every COVID-19 death to us: Centre to Delhi govt
The Ministry of Home Affairs (MHA) on Sunday asked the Delhi government to delineate all containment zones afresh and enumerate all households even outside
BMC to increase bed capacity to 1L by June-end in Mumbai
BMC Municipal commissioner IS Chahal said that BMC will increase bed capacity in Mumbai from the current 84,000 to 1 lakh by June-end for
Religious gatherings behind increase in coronavirus cases: WHO
Many countries that have been successful in tackling COVID-19 are seeing an increase in cases, World Health Organization's COVID-19 Technical Lead Maria Van Kerkhove
School of Pharmaceutical Sciences at Apeejay Stya University announces admissions for B. Pharm and D. Pharm
The School of Pharmaceutical Sciences at Apeejay Stya University (ASU) has announced admissions for the year 2020-21 in Diploma in Pharmacy (D. Pharm), Bachelor
Abbott to Supply More Than a Million Tests of IgG Lab-based Antibody Tests to India
Abbott's SARS-CoV-2 IgG test can be used for highly-reliable, large-scale antibody testing, in line with the ICMR recommendation for the use of IgG CLIA
India’s 1st COVID-19 drug FabiFlu launched, priced at ₹103/tablet
Drug firm Glenmark Pharmaceuticals on Saturday said that it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients